CE vs ITRM · rev $10.28B vs rev $390.0K
Celanese Corporation (CE) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
CE currently screens at market cap $5.92B. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the CE and ITRM stock pages for the full models.
Not investment advice.